Search

Your search keyword '"van Schayck, O. C."' showing total 4 results
Start Over Author "van Schayck, O. C." Language dutch; flemish
4 results on '"van Schayck, O. C."'

1. Mensen helpen bij stoppen met roken: Effectiviteit en veiligheid van interventies

Author

van de Graaf, R C, van Schayck, O C P, Family Medicine, and RS: CAPHRI - R5 - Optimising Patient Care

Subjects
Journal Article, English Abstract
Abstract

This review evaluates the safety and efficacy of, smoking cessation interventions.- Behavioural counselling is the cornerstone of smoking cessation programmes.- This counselling can be supplemented with written self-help materials, telephone counselling and e-health tailored to individual patient preferences.- Behavioural counselling may be combined with pharmacotherapy for increased effectiveness. First choice is a combination of a nicotine patch and a nicotine lozenge or chewing gum, mainly because of the favourable side-effect profile.- Furthermore, varenicline, bupropion and nortripyline are effective in smoking cessation; varenicline appears to be the most effective drug. These drugs have, however, more contraindications and potential side effects, which necessitates a correct diagnosis and more intensive monitoring.- The e-cigarette is not recommended as it seems to be equally efficacious as nicotine replacement therapy, but its potential side effects - such as normalising smoking - have not been sufficiently investigated.

Published
2017

2. Effectiviteit van de ‘Ziektelastmeter COPD’: Een clustergerandomiseerde gecontroleerde trial

Author

van Schayck, O C P, Slok, A H M, Kotz, D, van Breukelen, G, Chavannes, N H, Rutten-van Mölken, M P M H, Kerstjens, H A M, van der Molen, T, Asijee, G M, Dekhuijzen, P N R, Holverda, S, Salomé, P L, Goossens, L M A, Twellaar, M, In 't Veen, J C C M, and Groningen Research Institute for Asthma and COPD

Abstract

Doel Beoordelen van het effect van de ‘Ziektelastmeter COPD’ op de ziektespecifieke kwaliteit van leven bij patiënten met COPD. Opzet Clustergerandomiseerde gecontroleerde trial. Methode Dit betrof een onderzoek in 39 Nederlandse huisartsenpraktijken en 17 ziekenhuizen bij 357 patiënten met COPD (postbronchodilatoire FEV1/FVC-ratio: < 0,7) van 40 jaar of ouder. We randomiseerden zorgverleners tussen een interventie- en controlegroep, waarbij patiënten uit de interventiegroep behandeld werden met behulp van de ‘Ziektelastmeter COPD’. Dit innovatieve instrument bestaat uit een korte gevalideerde vragenlijst en een aantal objectieve parameters, die samen de integrale gezondheidstoestand visueel weergeven en via een behandelalgoritme leiden tot een individueel zorgplan. Patiënten uit de controlegroep ontvingen de gebruikelijke zorg. De primaire uitkomstmaat was het aantal patiënten met een klinisch relevante verbetering in ziektespecifieke kwaliteit van leven gemeten met de ‘St. George’s respiratory questionnaire’ (SGRQ) na een follow-upduur van 18 maanden. Secundaire uitkomstmaten waren onder andere de SGRQ-totaalscore en de ‘Patient assessment of chronic illness care’(PACIC)-score. Resultaten Na 18 maanden was er een statistisch significant en klinisch relevante toename in de SGRQ-score bij 49 patiënten (34%) in de interventiegroep en bij 33 patiënten (22%) in de controlegroep (oddsratio: 1,85; 95%-BI: 1,08-3,16). Patiënten in de interventiegroep ervoeren een hogere kwaliteit van zorg dan die in de controlegroep (verschil in PACIC-score: 0,32; 95%-BI: 0,14-0,50). Conclusie Gebruik van de ‘Ziektelastmeter COPD’ resulteert in een hogere ziektespecifieke kwaliteit van leven en hogere kwaliteit van zorg voor COPD-patiënten. Dit instrument kan een veelbelovende bijdrage leveren aan de dagelijkse COPD-zorg. We adviseren deze studie te repliceren, zo mogelijk in de buitenlandse gezondheidszorg.

Published
2016

3. [Helping people to give up smoking; efficacy and safety of smoking cessation interventions].

Author

van de Graaf RC and van Schayck OC

Subjects
Cognitive Behavioral Therapy, Electronic Nicotine Delivery Systems, Humans, Smoking, Varenicline, Nicotinic Agonists administration & dosage, Smoking Cessation methods
Abstract

- This review evaluates the safety and efficacy of, smoking cessation interventions.- Behavioural counselling is the cornerstone of smoking cessation programmes.- This counselling can be supplemented with written self-help materials, telephone counselling and e-health tailored to individual patient preferences.- Behavioural counselling may be combined with pharmacotherapy for increased effectiveness. First choice is a combination of a nicotine patch and a nicotine lozenge or chewing gum, mainly because of the favourable side-effect profile.- Furthermore, varenicline, bupropion and nortripyline are effective in smoking cessation; varenicline appears to be the most effective drug. These drugs have, however, more contraindications and potential side effects, which necessitates a correct diagnosis and more intensive monitoring.- The e-cigarette is not recommended as it seems to be equally efficacious as nicotine replacement therapy, but its potential side effects - such as normalising smoking - have not been sufficiently investigated.

Published
2017

4. [Effectiveness of the Assessment of Burden of COPD tool: a cluster-randomised controlled trial].

Author

van Schayck OC, Slok AH, Kotz D, van Breukelen G, Chavannes NH, Rutten-van Mölken MP, Kerstjens HA, van der Molen T, Asijee GM, Dekhuijzen PN, Holverda S, Salomé PL, Goossens LM, Twellaar M, and In 't Veen JC

Subjects
Aged, Female, Humans, Male, Middle Aged, Surveys and Questionnaires, Primary Health Care methods, Pulmonary Disease, Chronic Obstructive therapy, Quality Improvement, Quality of Life
Abstract

Objective: Assessment of the effectiveness of the Assessment of Burden of COPD (ABC) tool on disease-specific quality of life in patients with Chronic Obstructive Pulmonary Disease (COPD)., Design: Cluster-randomised controlled trial., Method: This concerned a trial in 39 Dutch primary care practices and 17 hospitals, involving 357 patients with COPD (postbronchodilator FEV1/FVC ratio < 0.7) aged ≥ 40 years. Healthcare providers were randomized to an intervention or control group. Patients in the intervention group were treated with the ABC tool. This innovative tool consists of a short validated questionnaire and a number of objective parameters, which collectively give a visual overview of the combined integral health; the tool subsequently produces an individualized treatment plan by means of a treatment algorithm. Patients in the control group received usual care. The primary outcome measure was the proportion of patients with a clinically relevant improvement in disease-specific quality of life measured, as measured by means of the St. George's Respiratory Questionnaire (SGRQ) score, between baseline and 18 months follow-up. Secondary outcomes included the SGRQ total score and the Patient Assessment of Chronic Illness Care (PACIC) score., Results: At 18-month follow-up, a significant and clinically relevant improvement in the SGRQ score was seen in 34% of the patients (N=49) in the intervention group, and in the control group this figure was 22% (N=33). This difference between the two groups was significant (OR 1.85, 95% CI 1.08 to 3.16). Patients in the intervention group experienced a higher quality of care than patients in the control group (0.32 points difference in PACIC, 95% CI 0.14 to 0.50)., Conclusion: Use of the ABC tool increases the disease-specific quality of life and the quality of care for COPD patients; it may therefore offer a valuable contribution to improvements in the daily care of COPD. Replication of this study in other (non-Dutch) health-care settings is recommended.

Published
2016

Catalog

Books, media, physical & digital resources
See catalog results